Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine. (Record no. 29531207)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01653 a2200433 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518032003.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202009s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1873-2518 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.vaccine.2019.03.052 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Godi, Anna |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20200916 |
245 00 - TITLE STATEMENT | |
Title | Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Vaccine |
Date of publication, distribution, etc. | 04 2019 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2455-2462 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Neutralizing |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Viral |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cross Protection |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Papillomaviridae |
General subdivision | classification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Papillomavirus Infections |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Papillomavirus Vaccines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Panwar, Kavita |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Haque, Mahmoud |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cocuzza, Clementina E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Andrews, Nick |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Southern, Jo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Turner, Paul |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Miller, Elizabeth |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Beddows, Simon |
773 0# - HOST ITEM ENTRY | |
Title | Vaccine |
Related parts | vol. 37 |
-- | no. 18 |
-- | p. 2455-2462 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.vaccine.2019.03.052">https://doi.org/10.1016/j.vaccine.2019.03.052</a> |
Public note | Available from publisher's website |
No items available.